Congressional leaders’ proposal to keep the Food and Drug Administration operating for the rest of fiscal year 2024 instructs the agency to find $7m within its budget to reallocate to implementing its expanded regulatory toolkit for cosmetics.
A budget agreement reached by House and Senate leaders and a conference committee, which they published with their bill, HR...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?